Granules pharmaceuticals stock
WebMar 28, 2024 · Granules is ready to start shipping medications right from Prince William County. On Tuesday, the India-based pharmaceutical maker opened up its new packaging and distribution facility just ... WebJul 3, 2024 · Granules India announced that its subsidiary, Granules Pharmaceuticals Inc. is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of N- Nitrosodimethylamine (NDMA) levels above the Acceptable Daily Intake …
Granules pharmaceuticals stock
Did you know?
WebMay 17, 2024 · About Granules India Ltd. (BSE: 532482) and (NSE: GRANULES) Granules India is a growing pharmaceutical manufacturing company with best in class facilities and is committed to operational ... WebPharmaceuticals. Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing presence across the …
WebThe Granules India PE ratio based on its reported earnings over the past 12 months is 11.45.The shares last closed at IN₹285.45.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Granules India. Use the PitchBook Platform to explore the full profile. ... Granules Biocause Pharmaceuticals: 06-Mar-2007: Joint Venture: Drug Discovery: To view Granules India’s complete investments and acquisitions history, request access »
WebTrospium Chloride Extended-release Capsules. Details. Valganciclovir Hydrochloride for Oral Solution, USP. Details. Vigabatrin for Oral Solution, USP. Details. Bupropion … Web1 day ago · On Wednesday, the BSE Healthcare index was the top sectoral performer. It rose 2.2% to its highest level in three months to close at 22,883.08. In comparison, benchmark indices posted marginal gains to extend the rally for the eight straight sessions. The Sensex closed at 60,392.77, up 235.05 points, or 0.39%, from the previous close.
WebApr 12, 2024 · The Company sells its products in the global markets, including United States of America, Canada, Latin America, Europe, Asia Pacific and India. Its wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
WebJan 28, 2024 · View 12 reports from 6 analysts offering long term price targets for Granules India Ltd.. Granules India Ltd. has an average target of 375.83. The consensus estimate represents an upside of 25.53% from the last price of 299.40. Reco - This broker has downgraded this stock from it's previous report. in an impulse turbine the quizletWebJul 27, 2024 · Granules Pharmaceutical Inc. (GPI), Chantilly, VA, a wholly owned subsidiary of Granules India Limited, would like to clarify that there has been no … in an impartial wayWebF&O Quote of Granules India Share Price, Future and Options Granules India Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Granules India, Granules India News, Videos, Stock ... duty stations of adaWebJan 24, 2024 · ANI. Published On Jan 24, 2024 at 05:45 PM IST. Hyderabad (Telangana): Granules India announced on Tuesday that the US Food and Drug Administration (US FDA) has approved the abbreviated new drug ... duty status changeWebGranules. Pharmaceuticals · India · 2,789 Employees . Granules, headquartered in Hyderabad, India, is a pharmaceutical company specializing in off-patent drugs. Their … duty status change 4187 armyWebMar 15, 2024 · Announcing: Granules India (NSE:GRANULES) Stock Increased An Energizing 198% In The Last Year Dec 28. Insider recently sold ₹3.8m worth of stock Dec 23. New 90-day low: ₹343 Dec 21. ... High growth companies in the Pharmaceuticals & Biotech industry. View Past Performance. duty status change 4187 examplein an illusion